Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

NIDA Home > Publications > Director's Reports > May, 2009 Index    

Director's Report to the National Advisory Council on Drug Abuse - May, 2009



Planned Meetings

The National Institute on Drug Abuse (NIDA) is organizing a program at the American Psychiatric Association (APA) Annual Meeting in San Francisco, May 16-21, 2009. A number of NIDA staff and NIDA researchers will participate in several symposia and workshops at the upcoming meeting on a wide range of topics such as, Diversion of Prescription Stimulants; Imaging Insight: Basic Definitions, Measures, and Relevance to Psychopathology; Older Adults and the Neurobiology of Substance Abuse; Clinical Challenges Identifying and Treating Unpresented Co-morbidity; Integrating Treatment for Substance Use and Post-Traumatic Stress Disorders in Patients with Co-Occurring Conditions; and, Genetic Vulnerabilities for Drug Abuse and Co-Morbid Mental Health Disorders. This program will build on previous tracks NIDA has been conducting at the APA Annual meeting since 1998.

The National Institute on Drug Abuse (NIDA) is organizing a program at this year's American Psychological Association (APA) Annual Meeting in Toronto, Canada, August 6-9, 2009. A number of NIDA staff throughout the Institute are involved in organizing symposia on a wide range of topics. NIDA will also co-sponsor an Early Career Investigator Poster Session with APA's Divisions 28 and 50 and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) as part of the two Divisions' Social Hour.

Dr. Harold Gordon, DCNBR, will chair a symposium entitled, Sleep Disturbances and Circadian Disruptions Affecting, and Affected by, Addiction to Drugs at the American Psychiatric Association annual meeting in San Francisco, May 16-21, 2009. The purpose is to present NIDA-funded research on sleep physiology and how it is altered by abused drugs, how to identify signs and symptoms of drug-abuse-related insomnia and cognitive deficits, what are the disruptions in the circadian clock related to cocaine, what are the reciprocal interactions between sleep and the immune system in substance dependence, and what are the treatment issues related to sleep disturbances in cocaine and opiate dependent individuals.

Dr. Steven Grant, DCNBR, will co-chair a workshop entitled, Imaging Insight: Basic Definitions, Measures, and Relevance To Psychopathology at the American Psychiatric Association annual meeting in San Francisco, May 16-21, 2009. The workshop will focus on evidence that dysregulation of specific brain systems may impair the ability of substance abusers to have accurate insight into their behavior.

Cora Lee Wetherington, DBNBR, and Wendy Lynch (University of Virginia) will co-chair the symposium, "Biological Basis of Sex Differences in Drug Abuse: A Translational Perspective," at the annual meeting to the American Psychiatric Association, May 16-21, 2009 in San Francisco, CA. Presenters will be Wendy Lynch, Ph.D. (University of Virginia), Jill Becker, Ph.D. (University of Michigan), Karen Berman, M.D. (NIMH), Marc Potenza, M.D., Ph.D. (Yale University School of Medicine), and Larry Cahill, Ph.D. (UC Irvine).

Minda Lynch and Joni Rutter, DBNBR are co-chairing a symposium at this year's American Psychiatric Association Convention entitled "Genetic Vulnerabilities for Drug Abuse and Co-Morbid Mental Health Disorders". Participants in this session, scheduled for May 21, 2009, include: Harriet de Wit, Ph.D. - Subjective Drug Effects as Endophenotypes for Vulnerability, Teresa Franklin, Ph.D. - The Influence of Genetic Variance in the Dopamine Transporter on Brain and Behavioral Responses to Smoking Cues, Caryn Lerman, Ph.D. - Interacting Effects of COMT Genotype and Nicotine Withdrawal on Brain Function and Cognition, Joel Gelernter, M.D., Yale University - Approaching Comorbidity in Addiction Genetics, and Howard Edenberg, Ph.D., Indiana University School of Medicine - Genetics of Alcoholism and Related Endophenotypes.

A NIDA-OSPC supported symposium entitled Integrating Treatment for Substance Use and Post-Traumatic Stress Disorders in Patients with Co-occurring Conditions has been accepted for presentation at the 2009 American Psychiatric Association Annual Meeting May 16-21, 2009. Dr. Udi Ghitza, CCTN, will chair this event. At the conclusion of this symposium, participants should have increased knowledge of: (1) prevalence of co-occurring post-traumatic stress disorder (PTSD) and substance use disorders (SUD) in both civilian and returning veteran populations, (2) psychotherapy treatment programs developed for patients with co-occurring SUD and PTSD, (3) pharmacotherapy treatment programs for these patients, and (4) challenges and opportunities for advancing an integrated medical care approach concurrently treating functional impairments associated with both SUD and PTSD.

Dr. Petra Jacobs will co-chair with Dr. Richard Denisco, DESPR, the NIDA/Prescription Opioid and Pain Workgroup-sponsored workshop entitled "Opioid Agonist Medications Effects on Cardiovascular System." This workshop will be held on June 16, 2009.

The College on Problems of Drug Dependence (CPDD) will hold its 71st annual meeting June 20-25, 2009, in Reno/Sparks, Nevada. CCTN staff will participate in the following:

  1. Dr. Raul Mandler will chair a mini symposium entitled, "HIV Risk Prevention in the CTN."
  2. A poster presentation by Ms. Carmen Rosa and Dr. Paul Wakim on "Participation in Substance Abuse Clinical Trials: Comparing Gender and Racial/Ethnic Groups" will be presented on June 25, 2009.
  3. A poster presentation by Drs. Steven Sparenborg, Udi Ghitza, and Betty Tai on "Comparative effectiveness research in the National Drug Abuse Treatment Clinical Trials Network (CTN)" will be presented on June 25, 2009.

A NIDA-OSPC supported meeting entitled Narrowing the Research-Practice Divide in Evidence-Based Medicine with Adoption of Electronic Medical Record Systems: Present and Future Directions will be held in Rockville, Maryland on July 13-14, 2009. Dr. Udi Ghitza, CCTN, will co-chair this event. An aim of this two-day meeting is to explore the prospects and challenges of utilizing interoperable electronic medical record systems to bridge the gap between specialized substance abuse treatment and mainstream medical care. To do so, this meeting will examine the ethical, policy, privacy, logistical, regulatory, technical, and financial challenges of developing and implementing integrated compatible electronic medical record systems in evidence-based behavioral research and healthcare settings with a special focus on substance abuse screening, treatment, and follow-up.

NIDA will host the eighth Blending Conference at the Albuquerque Convention Center in Albuquerque, New Mexico on April 22-23, 2010. This 2-day conference is designed to bring clinicians and researchers together to examine the most up-to-date scientific drug abuse and addiction findings and their application to clinical practice. NIDA's Deputy Director, Dr. Timothy Condon, is overseeing all conference planning activities, Dr. Cindy Miner (OSPC) conducted the site visit and is working with Dr. Denise Pintello (OD), who is coordinating meetings with the two CTN Nodes co-hosting the Blending Conference.


Index

Research Findings

Program Activities

Extramural Policy and Review Activities

Congressional Affairs

International Activities

Meetings and Conferences

Media and Education Activities

Planned Meetings

Publications

Staff Highlights

Grantee Honors



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal